Compare SNT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNT | VNRX |
|---|---|---|
| Founded | 1965 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.2M | 38.2M |
| IPO Year | 1993 | N/A |
| Metric | SNT | VNRX |
|---|---|---|
| Price | $4.60 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 68.4K | ★ 2.2M |
| Earning Date | 11-25-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 257.88 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $37,837,000.00 | $1,472,007.00 |
| Revenue This Year | N/A | $55.98 |
| Revenue Next Year | N/A | $420.37 |
| P/E Ratio | $23.21 | ★ N/A |
| Revenue Growth | 9.82 | ★ 14.48 |
| 52 Week Low | $2.57 | $0.22 |
| 52 Week High | $5.34 | $0.94 |
| Indicator | SNT | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 63.29 | 45.05 |
| Support Level | $3.10 | $0.22 |
| Resistance Level | $4.95 | $0.26 |
| Average True Range (ATR) | 0.30 | 0.02 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 81.13 | 60.42 |
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.